跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ampicent-1 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ampicent-1
Approved
STANDARD
Ampicent-1
North China Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0ef4ed5938d40b5e
Company
North China Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
0ef4ed5938d40b5e
Drug Approval Philippines Name
Ampicent-1
Product Name
Ampicent-1
Registration Number
DRP-6136-04
Brand Name
Ampicent-1
Generic Name
Ampicillin (as sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
1 g
Manufacturer
North China Pharmaceutical Co., Ltd
Importer
Aglobal Care, Inc
Distributor
Central West Medicale Inc
Issuance Date
27 February 2024
Expiry Date
13 March 2029
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0ef4ed5938d40b5e
Type
Standard
Back to Philippines FDA Approvals